Ghrelin Receptor Signaling: A Promising Therapeutic Target for Metabolic Syndrome and Cognitive Dysfunction

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|9|5|557-563

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.9, Iss.5, 2010-11, pp. : 557-563

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Peripheral Benzodiazepine Receptor: A Promising Therapeutic Drug Target

By  

Current Medicinal Chemistry, Vol. 10, Iss. 16, 2003-08 ,pp. : 1563-1572

Bentham Science Publishers

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptor (PPAR)&bgr; /&dgr;: A New Potential Therapeutic Target for the Treatment of Metabolic Syndrome

By  

Current Molecular Pharmacology, Vol. 2, Iss. 1, 2009-01 ,pp. : 46-55

Bentham Science Publishers

Access to resources Recommend Favorite

Activin Receptor Signaling: A Potential Therapeutic Target for Osteoporosis

By  

Current Molecular Pharmacology, Vol. 5, Iss. 2, 2012-06 ,pp. : 195-204

Bentham Science Publishers

Access to resources Recommend Favorite

Cannabinoid Receptor Antagonists and the Metabolic Syndrome: Novel Promising Therapeutical Approaches

By  

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 1, 2007-01 ,pp. : 21-30

Bentham Science Publishers

Access to resources Recommend Favorite

Peroxisome proliferator-activated receptor β/δ as a therapeutic target for metabolic diseases

By Bedu Elodie   Wahli Walter   Desvergne Béatrice  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 4, 2005-08 ,pp. : 861-873

Informa Healthcare

Access to resources Recommend Favorite